Development of chromatographic and electrophoretic methods for determining vinblastine in blood plasma and prostate gland tissue

Two methods have been developed for determining antitumor drug vinblastine in blood plasma and prostate gland tissue by high performance liquid chromatography ( HPLC ) and capillary electrophoresis ( CE ) with detection at 214 nm. The lower limit of quantitative determination (15 ng/mL) was achieved...

Full description

Saved in:
Bibliographic Details
Published in:Journal of analytical chemistry (New York, N.Y.) N.Y.), 2013-03, Vol.68 (3), p.265-271
Main Authors: Sidorova, A. A., Yaroshenko, D. V., Murashko, E. A., Grigor’ev, A. V.
Format: Article
Language:English
Subjects:
Analytical Chemistry
Blood plasma
Chemical properties
Chemistry
Chemistry and Materials Science
Composition
Electrophoresis
High performance liquid chromatography
Identification and classification
Methods
Pharmaceutical chemistry
Physiological aspects
Prostate
Vinblastine
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Two methods have been developed for determining antitumor drug vinblastine in blood plasma and prostate gland tissue by high performance liquid chromatography ( HPLC ) and capillary electrophoresis ( CE ) with detection at 214 nm. The lower limit of quantitative determination (15 ng/mL) was achieved with HPLC. The higher accuracy ( CV ), precision and selectivity have been achieved with CE method, 0.09, 90, and 100%, respectively. The sample preparation of blood plasma and previously homogenized prostate gland tissue included solid-phase extraction on Supelco DSC-18 cartridges. The recovery of vinblastine from the blood plasma was 91 ± 3% and from the tissue, 82 ± 5% ( n = 6). The developed methods were implemented for the therapeutic monitoring of vinblastine in the procedure of intracavitary drug electrophoresis.
ISSN:1061-9348
1608-3199
DOI:10.1134/S1061934813030118